Top 5 Takeaways Increase in Group A Streptococcus Bacteremia: The University of Vermont Medical Center noted a substantial rise in cases of group A streptococcal bloodstream infections during 2022–2023, primarily
Blog
Top 5 Takeaways New Vaccination Recommendation: As of February 28, 2024, the Advisory Committee on Immunization Practices (ACIP) recommends an additional dose of the updated (2023–2024 Formula) COVID-19 vaccine for
Top 5 Takeaways Rapid Outbreak Following School Event: An outbreak of influenza A(H3N2) occurred among attendees of a school banquet, with 41% of students reporting symptoms within a median of
Case-control studies are a cornerstone of population research, offering insights into the factors that may contribute to the occurrence of diseases or conditions. These studies are particularly invaluable in understanding
Top 5 Takeaways Higher barriers to healthcare for adults with epilepsy: Compared to adults without epilepsy, those with active or inactive epilepsy face more significant challenges in accessing necessary medical
Top 5 Takeaways Significant Decline During Early Pandemic: The early phase of the COVID-19 pandemic saw a sharp decrease in seizure- or epilepsy-related emergency department (ED) visits across all age
Top 5 Takeaways Link between SDOH, HRSNs, and Mammography: Women experiencing more adverse Social Determinants of Health (SDOH) and Health-Related Social Needs (HRSNs) reported lower mammography use, highlighting significant barriers
Top 5 Takeaways New Vaccine Approval: The FDA has approved the Pfizer Pentavalent Meningococcal Vaccine (MenACWY-TT/MenB-FHbp, branded as Penbraya) for individuals aged 10–25 years to protect against serogroups A, B,
Top 5 Takeaways High Infection and Hospitalization Rates: Throughout the study period, SARS-CoV-2 infection rates ranged from 61.4 to 133.8 per 10,000 nursing home residents, with a peak of 133.8
Top 5 Takeaways Initial Vaccine Effectiveness: The original monovalent mRNA COVID-19 vaccine was 52% effective in preventing COVID-19-related hospitalization in children and adolescents when the last dose was received within
